Corteva (CTVA) Vylor Investor Day 2026 summary

Strategic transformation, vision, and growth drivers

• Transitioning from a traditional seed seller to a high-margin, technology-driven genetics platform, leveraging proprietary germplasm, AI, and IP monetization, with a decade-plus growth algorithm targeting several billion dollars in bottom-line growth from next-gen technology starting in 2027.

• Launching 12 new technology platforms, including gene editing, hybrid wheat, and advanced trait stacks for corn and soybeans, with hybrid wheat expected to deliver 10%-20% yield improvements and generate $1B in revenue by 2040, first U.S. launch in 2027.

• Expanding addressable market beyond traditional row crops through licensing, gene editing, and biofuels, targeting a $75B market by 2035.

• Transitioning to royalty-positive licensing, targeting $1B net licensing income by 2035 and $2B annual licensing revenue by 2040, driven by increased out-licensing and reduced royalty expenses.

• Leveraging gene editing to accelerate innovation, with the first gene-edited, multi-disease-resistant corn hybrid launching later this decade and plans to expand into new crops and markets.

Financial framework, guidance, and capital allocation

• Targeting 3%-4% annual revenue growth and 7%-8% EBITDA growth through 2029, with EBITDA margins expanding from 27% to 30% and free cash flow conversion of 60% or better.

• Net sales projected at $10.4B in 2026, growing to $11.2–$11.9B by 2029, with $3.3–$3.7B operating EBITDA and $5.5–$6.5B cumulative FCF from 2027–2029.

• Committing approximately $1B annually to R&D (10% of sales), $1B annual share repurchases (excluding major M&A), growing dividends, and balanced capital allocation: 20% to capex, 15% to dividends, and 65% to M&A and buybacks.

• Disciplined M&A focused on wheat, gene editing, and adjacent crops, with strict return criteria; organic growth, licensing, and productivity remain the foundation.

• Financial projections assume stable crop prices and planted area, with growth driven by technology adoption, share gains, and operational leverage.

Competitive advantages, innovation, and operational excellence

• Deep competitive moat built on proprietary germplasm, global R&D and production footprint, AI-driven R&D and operations, and trusted farmer relationships, including a 90% North American customer retention rate.

• Leading positions in major markets, rapid share gains in Brazil soybeans, and a robust pipeline of new products and traits.

• Integrated One Seed operating model connects R&D, production, and commercialization, driving $500M in productivity gains over five years and supporting scalable, high-quality supply.

• Innovation pipeline valued at $19B, with 12 new technology platforms launching over the next decade and a focus on solving global agricultural challenges through advanced genetics.

• Doubling annual genetic gain by 2035 through advanced breeding, gene editing, and AI-driven analytics.